|
It was reported, under microscopic view, impurities were observed in the transfer catheter of a guardia¿ access embryo transfer catheter.The catheter was not used.A new transfer catheter was used to complete the embryo transfer procedure.The patient did not require any additional procedures due to this occurrence.The complainant has not reported any adverse effects on the patient due to this occurrence.
|
|
Correction: d4 (primary udi number).Investigation ¿ evaluation.It was reported, under microscopic view, impurities were observed in the transfer catheter of a guardia¿ access embryo transfer catheter.The catheter was not used.A new transfer catheter was used to complete the embryo transfer procedure.The patient did not require any additional procedures due to this occurrence.The complainant has not reported any adverse effects on the patient due to this occurrence.Reviews of the complaint history, device history record (dhr), specifications, instructions for use (ifu), manufacturer¿s instructions (mi), and quality control (qc) procedures as well as a visual inspection of the returned device, were conducted during the investigation.One transfer catheter without the guide catheter was returned to cook for evaluation.After wiring the transfer catheter, a dried material inside the tubing was able to be pushed out as well as a piece of unknown opaque foreign material in tubing near the cannula tip.Additionally, a document-based investigation evaluation was performed.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.A review of the dhrs for the reported complaint device lot and the related subassembly lots revealed no recorded discrepancies relevant to the failure mode.A review of complaint history records found one other related complaints associated with the failure mode for the complaint device lot.Based on the complaint review and the individual controls in place, it is unlikely the reported issue impacted the entire lot.Based on the available information, cook has concluded that the device was manufactured to specification and that there is no evidence suggesting nonconforming products exist either in house or in the field.Cook also reviewed product labeling; the ifu supplied with the device states the following in consideration of the reported failure mode: note: one cell mea tested and passed with 80% or greater blastocyst development within 96 hrs.Usp endotoxin (lal) tested and passed with 20 eu or less per device.Based upon the available information, inspection of the returned device, and results of the investigation, cook has concluded that a definitive cause for this event could not be established.The appropriate personnel have been notified.Cook will continue to monitor for similar complaints.Per the risk assessment, no further action is required.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|